H05AA03 • parathyroid hormone • Systemic hormonal preparations, excluding sex hormones and insulins | Parathyroid hormones and analogues
Parathyroid hormone (PTH) is used in the treatment of severe osteoporosis in patients at high risk of fractures. It stimulates bone formation by increasing osteoblast activity and improving calcium metabolism.
The medication is administered subcutaneously, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor bone health.
Patients should be aware of potential side effects, such as nausea, joint pain, or dizziness. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, joint pain, and dizziness. In rare cases, severe reactions such as hypercalcemia or allergic reactions may occur. Patients should be informed of these risks before use.
Substance: parathyroid hormone
Date of last drug list: 01-07-2013
Commercial code: W51659002
Concentration: 100mcg
Pharmaceutical form: powder + solvent for injection
Quantity: 6
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).